ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

TRVI Company Profile and Key Details

NASDAQ : TRVI

Trevi Therapeutics, Inc.

$4.30

0.01+0.23%

At Close 4:00 PM

$6.07

1.77+41.16%

After-Market 04:15 PM

58.29

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

TRVI Stock Price Chart

Stock Price Today

Trevi Therapeutics, Inc. (TRVI) stock surged +41.16%, trading at $6.07 on NASDAQ, up from the previous close of $4.30. The stock opened at $6.59, fluctuating between $5.70 and $7.39 in the recent session.

Stock Snapshot

4.3

Prev. Close

6.59

Open

542.45M

Market Cap

89.37M

Number of Shares

5.7001

Day Low

7.39

Day High

-13.8

P/E Ratio

59.13%

Free Float in %

-0.44

EPS (TTM)

0.83

Book Value

-0.32

Cash Flow per Share

57.49M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	4.29	4.55	4.24	4.30	1.07M
Mar 06, 2025	4.33	4.47	4.29	4.29	715.13K
Mar 05, 2025	4.56	4.59	4.24	4.39	644.57K
Mar 04, 2025	4.34	4.52	4.22	4.44	1.11M
Mar 03, 2025	4.53	4.59	4.25	4.26	833.29K
Feb 28, 2025	4.49	4.70	4.17	4.52	767.63K
Feb 27, 2025	4.49	4.79	4.36	4.50	867.6K
Feb 26, 2025	4.41	4.71	4.39	4.51	571.03K
Feb 25, 2025	4.31	4.53	4.09	4.52	1.1M
Feb 24, 2025	4.73	4.73	4.29	4.31	1.78M
Feb 21, 2025	5.00	5.05	4.55	4.60	1.9M
Feb 20, 2025	4.78	4.89	4.56	4.80	3.6M
Feb 19, 2025	4.22	4.59	4.11	4.57	848.57K
Feb 18, 2025	4.05	4.29	3.96	4.22	964.75K
Feb 14, 2025	4.04	4.13	3.93	4.07	682.03K
Feb 13, 2025	4.10	4.14	3.95	4.01	324.4K
Feb 12, 2025	3.90	4.09	3.77	4.05	244.67K
Feb 11, 2025	3.98	4.04	3.79	3.96	564.73K
Feb 10, 2025	4.23	4.30	4.01	4.06	491.3K
Feb 07, 2025	4.25	4.35	4.13	4.24	484.6K

Contact Details

New Haven, CT 06510

United States

Website: https://www.trevitherapeutics.comContact: 203 304 2499

About Company

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

Frequently Asked Questions

What is the current Trevi Therapeutics, Inc. (TRVI) stock price?

Trevi Therapeutics, Inc. (NASDAQ: TRVI) stock price is $6.07 in the last trading session. During the trading session, TRVI stock reached the peak price of $7.39 while $5.70 was the lowest point it dropped to. The percentage change in TRVI stock occurred in the recent session was 41.16% while the dollar amount for the price change in TRVI stock was $1.77.

TRVI's industry and sector of operation?

The NASDAQ listed TRVI is part of Biotechnology industry that operates in the broader Healthcare sector. Trevi Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TRVI?

Mr. Christopher Galletta
Controller & Chief Accounting Officer
Ms. Jennifer L. Good
Co-Founder, Chief Executive Officer, Pres & Director
Dr. Thomas R. Sciascia M.D.
Co-Founder & Chief Science Officer
Ms. Danine Summers
Vice President of Medical Affairs
Katie McManus
Communications Mang.
Mr. Farrell Simon Pharm.D.
Chief Commercial Officer
Dr. David J. Clark A.F.P.M., M.D., M.R.C.P.
Chief Medical Officer
Ms. Lisa Delfini
Chief Financial Officer

How TRVI did perform over past 52-week?

TRVI's closing price is 86.96% higher than its 52-week low of $2.30 where as its distance from 52-week high of $7.39 is -14.85%.

How many employees does TRVI have?

Number of TRVI employees currently stands at 27.

Link for TRVI official website?

Official Website of TRVI is: https://www.trevitherapeutics.com

How do I contact TRVI?

TRVI could be contacted at phone 203 304 2499 and can also be accessed through its website. TRVI operates from 195 Church Street, New Haven, CT 06510, United States.

How many shares of TRVI are traded daily?

TRVI stock volume for the day was 57.49M shares. The average number of TRVI shares traded daily for last 3 months was 1.95M.

What is the market cap of TRVI currently?

The market value of TRVI currently stands at $542.45M with its latest stock price at $6.07 and 89.37M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	27
Beta	0.91
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology